Mycophenolate Mofetil in Multiple Sclerosis: A Multicentre Retrospective Study on 344 Patients
JNNP 85:279-283,246, Michel, L.,et al, 2014
IgG4-Related Leptomeningitis: A Reversible Cause of Rapidly Progressive Cognitive Decline
Neurol 82:540-542, Mehta, S.H.,et al, 2014
Bevacizumab in Glioblastoma - Still Much to Learn
NEJM 370:764-765, Fine, H.A., 2014
Clinical Reasoning: A 30-year-old Woman with Recurrent Seizures and a Cerebral Lesion Progressing over 2 Decades
Neurol 82:e56-e58, Tonder, M.,et al, 2014
Clinical Radiologic Features of Encephalopathy during 2011 E Coli O111 outbreak in Japan
Neurol 82:564-572, Takanashi, J.,et al, 2014
Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014
Neuroimaging in Intracerebral Hemorrhage
Stroke 45:903-908, Macellari, F.,et al, 2014
4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014
The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014
Clinical Characteristics and Outcome of Brain Abscess
Neurol 82:806-813, Brouwer, M.C.,et al, 2014
Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014
Clinicopathologic Conference, Glioblastoma, WHO Grade IV, Involving Leptomeninges Consistent with Primary Leptomeningeal Gliomatosis
NEJM 370:1049-1059, Case 8-2014, 2014
CT Angiography Findings in Carotid Blowout Syndrome and Its Role as a Predictor of 1-Year Survival
AJNR35:562-567, Lee, C-W.,et al, 2014
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014
Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial
Lancet 383:2213-2221, Chataway, J.,et al, 2014
A Case of Rabies Encephalitis
Neurol 82:1101, Wilcox, M.E.,et al, 2014
Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling
Stroke 45:1222-1238, Wijdicks, E.F.M.,et al, 2014
Diagnosis and Management of Acute Cerebellar Infarction
Stroke 45:e56-e58, Wright, J.,et al, 2014
MATILDE Chemotherapy Regimen for Primary CNS Lymphoma
Neurol 82:1370-1373, Ferreri, A.J.M.,et al, 2014
Progressive Multifocal Leukoencephalopathy in Patients with Sarcoidosis
Neurol 82:1307-1313, Jamilloux, Y.,et al, 2014
Acute-Onset Homonymous Hemianopia with Hyperglycemia
Neurol 82:e129-e133, Strowd, R.E.,et al, 2014
Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
Stroke 45:2004-2009, Seners, P.,et al, 2014
ICU-Acquired Weakness and Recovery from Critical Illness
NEJM 370:1626-1635, Kress, J.P. & Hall, J.B., 2014
Rheumatoid Meningitis Presenting with Stroke-Like Episodes
Neurol 82:1564-1565, Bourgeois, P.,et al, 2014
Anti-HMGCR Autoantibodies in European Patients with Autoimmune Necrotizing Myopathies
Medicine 93:150-157, Allenbach, Y.,et al, 2014
Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014
Remote or Extraischemic Intracerebral Hemorrhage - An Uncommon Complication of Stroke Thrombolysis
Stroke 45:1657-1663, Mazya, M.V.,et al, 2014
Reperfusion Therapies for Wake-Up Stroke
Stroke 45:1869-1875, Buck, D.,et al, 2014
Safety of Thrombolysis in Patients with Acute Ischemic Stroke and Cerebral Cavernous Malformations
Stroke 45:1846-1848, Erdur, H.,et al, 2014
Traumatic Intracranial Hypertension
NEJM 370:2121-2130, Stocchetti, N. & Maas, A.I.R., 2014
Paraparetic Guillain-Barre Syndrome
Neurol 82:1984-1989, Van Den Berg, B.,et al, 2014
Brain Abscess
NEJM 371:447-456, Brouwer, M.C.,et al, 2014
A Woman with Subacute Progressive Confusion and Gait Instability
Neurol 83 ;e62-e67, Martinez-Thompson, J.M.,et al, 2014
Mold Infections of the Central Nervous System
NEJM 371:150-160, McCarthy, M.,et al, 2014
Effect of Rituximab in Patients with Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy
JAMA Neurol 71:896-900, Irani, S.R.,et al, 2014
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014
An Independent Elderly Woman with Rapid Onset of Coma
JAMA Neurol 71:1043-1047, Xu, J.,et al, 2014
Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
JAMA Neurol 81:1181-1185, Yaghi, S.,et al, 2014
Neuroimaging Features and Predictors of Outcome in Eclamptic Encephalopathy: A Prospective Observational Study
AJNR 35:1728-1734, Junewar, V.,et al, 2014
Cavernous Sinus Thrombosis: Linking a Swollen Red Eye and Headache
Lancet 384:928, Sakaida, H.,et al, 2014
A 47-year-old Woman with Left Shoulder Pain after a Fall
Neurol 83:e112-e116, Jerath, N.U.,et al, 2014
Neurological Manifestation of Recreational Fatal and Near-Fatal Diethylene Glycol Poisonings
Medicine 93:e62, Imam, Y.Z.B.,et al, 2014
Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014
Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014
Disseminated Varicella Zoster Virus Encephalitis
Lancet 384:1698, Chai, W. & Gong-Ruey Ho, M., 2014
Treatment of Langerhans Cell Histiocytosis
UptoDate Oct. 2014, McClain, K.L., 2014
Clinical Manifestations, Pathologic Features, and Diagnosis of Langerhans Cell Histiocytosis
UptoDate Oct. 2014, McClain, K.L., 2014
MRI Spot Sign
Neurol Clin Pract 4:528-529, Cutsforth-Gregory, J.K.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders
Adams & Victors Principles of Neurology, Chp 31, pg 639, Ropper, A.H.,et al, 2014